Identification of dissociated non-steroidal glucocorticoid receptor agonists

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 18, 2007, Pages 5025-5031

  Kuzmich, Daniel ^a   Kirrane, Tom ^a   Proudfoot, John ^a   Bekkali, Younes ^a   Zindell, Renee ^a   Beck, Laura ^a   Nelson, Richard ^a   Shih, Cheng Kon ^a   Kukulka, Alison J ^a   Paw, Zofia ^a   Reilly, Patty ^a   Deleon, Rodney ^a   Cardozo, Mario ^a   Nabozny, Gerald ^a   Thomson, David ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Anti inflammatory; Aromatase; Glucocorticoid receptor; Glucocorticoid receptor agonist; IL 6

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DEXAMETHASONE; NONSTEROIDAL GLUCOCORTICOID RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; ZK 16348;

ARTICLE; DEMETHYLATION; DRUG BINDING; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; ENZYME INDUCTION; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; X RAY CRYSTALLOGRAPHY;

GLUCOCORTICOIDS; LIGANDS; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34547919583     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.07.031     Document Type: Article

References (40)

1. Evans R.M. Science 240 (1988) 889
2. Beato M., Herrlich P., and Schutz G. Cell 83 (1995) 851
3. Barnes P.J. Clin. Sci. 94 (1998) 557
4. Hirschmann R. Steroids 57 (1992) 579
5. In: Goulding N.J., and Flowers R.J. (Eds). Glucocortocoids (2001), Birkhauser, Boston 35-54
6. Schacke H., Docke W.D., and Asadullah K. Pharmacol. Ther. 96 (2002) 23
7. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., Gass P., Schmid W., Herrlich P., Angel P., and Schutz G. Cell 93 (1998) 531
8. Bamberger C.M., and Schulte H.M. Eur. J. Clin. Invest. 30 Suppl. 3 (2000) 6
9. Leung D.Y.M., and Bloom J.W.J. Allergy Clin. Immunol. 111 (2003) 3
10. Eggert M., Schulz M., and Neeck G. J. Steroid Biochem. Mol. Biol. 77 (2001) 185
11. Belvisi M.G., Thomas J.B., Wicks S., and Foster M.L. Pulm. Pharmacol. Ther. 14 (2001) 221
12. Belvisi M.G., Wicks S., Battram C.H., Bottoms S.E.W., Redford J.E., Woodman P., Brown T.J., Webber S.E., and Foster M.L. J. Immunol. 166 (2001) 1975
13. Schacke H., Rehwinkel H., Asadullah K., and Cato A.C.B. Exp. Dermatol. 15 (2006) 565
14. Barker M., Clackers M., Demaine D.A., Humphreys D., Johnston M.J., Jones H.T., Pacquet F., Pritchard J.M., Salter M., Shanahan S.E., Skone P.A., Vinader V.M., Uings I., Upton R., McLay I.M., and Macdonald S.J.F. J. Med. Chem. 48 (2005) 4507
15. Barker M., Clackers M., Copley R., Demaine D.A., Humphreys D., Inglis G.G.A., Johnston M.J., Jones H.T., Haase M.V., House D., Loiseau R., Nisbet L., Pacquet F., Skone P.A., Shanahan S.E., Tape D., Vinader V.M., Washington M., Uings I., Upton R., McLay I.M., and Macdonald S.J.F. J. Med. Chem. 49 (2006) 4216
16. De Bosscher K., Berghe W.V., Beck I.M.E., Molle W.V., Hennuyer N., Hapgood C.L., Staels B., Louw A., and Haegeman G. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15827
17. Shah N., and Scanlan T.S. Bioorg. Med. Chem. Lett. 14 (2004) 5199
18. Ali A., Thompson C.F., Balkovec J.M., Graham D.W., Hammond M.L., Quraishi N., Tata J.R., Einstein M., Ge L., Harris G., Kelly T.M., Mazur P., Pandit S., Santoro J., Sitlani A., Wang C., Williamson J., Miller D.K., Thompson C.M., Zaller D.M., Forrest M.J., Carballo-Jane E., and Luell S. J. Med. Chem. 47 (2004) 2441
19. Coghlan M.J., Kym P.R., Elmore S.W., Wang A.X., Luly J.R., Wilcox D., Stashko M., Lin C.W., Miner J., Tyree C., Nakane M., Jacobson P., and Lane B.C. J. Med. Chem. 44 (2001) 2879
20. Lin X., and Hueber V. Curr. Opin. Drug Discovery Dev. 3 (2000) 383
21. Elmore S.W., Pratt J.K., Coghlan M.J., Mao Y., Green B.E., Anderson D.D., Stashko M.A., Lin C.W., Falls D., Nakane M., Miller L., Tyree C.M., Miner J.N., and Lane B. Bioorg. Med. Chem. Lett. 14 (2004) 1721
22. Lin C.W., Makane M., Stashko M., Falls D., Kuk J., Miller L., Huang R., Tyree C., Miner J.N., Rosen J., Kym P.R., Coghlan M.J., Carter G., and Lane B.C. Mol. Pharmacol. 62 (2002) 297
23. Regan J., Lee T.W., Zindell R.M., Bekkali Y., Bentzien J., Gilmore T., Hammach A., Kirrane T.M., Kukulka A.J., Kuzmich D., Nelson R.M., Proudfoot J.R., Ralph M., Pelletier J., Souza D., Zuvela-Jelaska L., Nabozny G., and Thomson D.S. J. Med. Chem. 49 (2006) 7887
24. Lehmann, M.; Krolikiewicz, K.; Skuballa, W.; Strehlke, P.; Kalkbrenner, F.; Ekerdt, R.; Giesen, C. WO 0032584, 2000.
25. Schacke H., Schottelius A., Docke W.D., Strehlke P., Jaroch S., Schmees N., Rehwinkel H., Hennekes H., and Asadullah K. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 227
26. Betageri R., Zhang Y., Zindell R.M., Kuzmich D., Kirrane T.M., Bentzien J., Cardozo M., Capolino A.J., Fadra T.N., Nelson R.M., Paw Z., Shih D.-T., Shih C.-K., Zuvela-Jelaska L., Nabozny G., and Thomson D. Bioorg. Med. Chem. Lett. 15 (2005) 4761
27. This work was previously disclosed in part: Kuzmich, D.; Kirrane, T.; Bekkali, Y.; Zindell, R.; Beck, L.; Nabozny, J.; Proudfoot, J.; Nelson, R.; Shih, S.-K.; Capolino, A.; Paw, Z.; Reilly, P.; Deleon, R.; Thomson, D. In Inflammation Research Association, 12th International Conference, October 3-7, Bolton Landing, NY, USA., Poster A039, 2004.
28. Bekkali, Y.; Cardozo, M. G.; Kirrane, T. M.; Kuzmich, D.; Proudfoot, J. R.; Takahashi, H.; Thomson, D.; Wang, J.; Zindell, R.; Harcken, C. H. J. J.; Razavi, H. PCT Int. Appl. WO 03/082787, 2003.
29. 50 standard deviations of 20-40% about the mean. The ER fluorescence polarization competitive binding assays were performed according to the protocol provided with the Panvera kit P-2614.
30. 50 values. Top concentration in the assay was 2 μM.
31. 50 standard deviations of 30-50% about the mean.
32. Berkovitz G.D., Bisat T., and Carter K.M. J. Steroid Biochem. 33 (1989) 341
33. Williams S.P., and Sigler P.B. Nature 393 (1998) 392 RCSB protein data bank id: 1A28
34. Bledsoe R.K., Montana V.G., Stanley T.B., Delves D.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., Lambert M.H., Moore J.T., Pearce K.H., and Xu E.H. Cell 110 (2002) 93
35. Bledsoe, R. K; Lambert, M. H.; Montana, V. G.; Stewart, E. L.; Xu, E. H. Eur. Pat. Appl. 1375517, 2004;
36. Kauppi B., Jakob C., Farnegardh M., Yang J., Ahola H., Alarcon M., Calles K., Engstrom O., Harlan J., Muchmore S., Ramqvist A.-K., Thorell S., Ohman L., Greer J., Gustafsson J.-A., Carlstedt-Duke J., and Carlquist M. J. Biol. Chem. 278 (2003) 22748 Figure 2a was generated from the GR-LBD/dexamethasone co-crystal structure deposited in the RCSB protein data bank (PBD ID 1P93)
37. Recently we reported the absolute stereochemistry of the more potent enantiomer in our series, see:. Lee T.W., Proudfoot J.R., and Thomson D. Bioorg. Med. Chem. Lett. 16 (2006) 654
38. (S)-Enantiomer of compound 3 was docked into the GR-LDB pocket using the GR-LBD/dexamethasone co-crystal structure deposited in the RCSB protein data bank (PBD ID 1P93) to afford Figure 2b. The docking studies were done using Cerius2, LigandFit. The docking site was defined using dexamethasone and enlarged to fill available space. The energy grid was calculated with a distance-dependent dielectric constant of 1.0 and a non-bonded cutoff distance of 10.0 Å and the grid was extended 5.0 Å from the site. Docking was performed with a flexible ligand. Clustering of the docked ligands was performed using complete linkage with a distance threshold of 1.5 Å. Site partitioning was used with one partition.
39. Tucker H., Crook J.W., and Chesterson G.J. J. Med. Chem. 31 (1988) 954
40. Fensome A., Bender R., Chopra R., Cohen J., Collins M.A., Hudak V., Malakian K., Lockhead S., Olland A., Svenson K., Terefenko E.A., Unwalla R.J., Wilhelm J.M., Wolfrom S., Zhu Y., Zhang Z., Zhang P., Winneker R.C., and Wrobel J. J. Med. Chem. 48 (2005) 5092